Expected Timeline and Results for Women Most women notice initial changes within 4-6 weeks of starting AOD 9604, with the most dramatic improvements occurring between weeks 8-12
Store at controlled room temperature (2025 C), protected from light
MOTS-c targets AMPK-dependent insulin sensitization Regulatory status / FDA lists both peptides among bulk drug substances under evaluation for compounding Why No Direct Comparison Exists Neither AOD-9604 nor MOTS-c has advanced far enough in clinical development for a randomized head-to-head trial
If nausea, headaches, or injection site reactions appear, you cannot tell whether lowering the dose would fix them
Its potential bodybuilding value is more indirect: Better soft-tissue recovery may reduce missed training days
It promotes carbohydrate metabolism, energises skeletal and cardiac muscle, and supports metabolic function